| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3925896 | European Urology | 2008 | 10 Pages |
Abstract
Among patients with AIPC treated with biweekly docetaxel and estramustine, baseline PSA >100, existence of pain, weight loss, and simultaneous extraosseous and bone disease were associated with worse prognosis. Extraosseous metastases seem to be more sensitive than bone disease to this chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Aristotle Bamias, George Bozas, Nikolaos Antoniou, Iraklis Poulias, Harilaos Katsifotis, Andreas Skolarikos, Dionysios Mitropoulos, Christos Alamanis, Gerassimos Alivizatos, Haralambos Deliveliotis, Meletios A. Dimopoulos,